Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Hypertension
Clinical trial register · Japan

Hypertension Trials in Japan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2516 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:19 UTC
2516
Studies in scope
all four open statuses
1285
Recruiting now
open to new participants
352
Lead sponsors
across recruiting studies
Top sites
Kamakura-shi 4 Chūōku 4 Yamato-shi 4 Matsuyama 3 Hachiōji 2

Hypertension trials in Japan

15 of 2516 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Not yet open
Novo Nordisk A/S
Phase 3
1,408
Yamato-shi, Arakawa-ku, Tokyo, Okayama, Sendai-shi, Miyagi, Tokyo
2026-11-11
Recruiting
Eli Lilly and Company
Phase 2
120
Hachiōji, Kamakura-shi, Naka, Narita
2026-08-27
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
30
Osaka
2026-08-01
Recruiting
Novartis Pharmaceuticals
Phase 1
64
Sumida Ku
2026-07-02
Not yet open
Covered vs Bare Metal Stents for Atherosclerotic Renal Artery Stenosis
NCT07566065Atherosclerotic Renal Artery Stenosis, Hypertension, Renal Artery Stenosis
Chinese Academy of Medical Sciences, Fuwai Hospital
Not applicable
150
2026-04-30
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Bunkyō City, Chikushino-shi, Chūōku, Fukuoka, Hachioji-Shi, Hachiōji, Hakodate-Shi, Hakusan
2025-09-06
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Aichi, Kariya, Aichi, Kasugai, Aichi, Nagoya, Chiba, Chiba, Chiba, Ichikawa, Chiba, Matsudo, Chiba, Narashino, Ehime, Matsuyama
2025-07-22
Active, closed
Eli Lilly and Company
Phase 3
487
Chūōku, Kamakura-shi, Matsuyama, Yamato-shi
2025-04-30
Active, closed
Eli Lilly and Company
Phase 3
487
Chūōku, Kamakura-shi, Matsuyama, Yamato-shi
2025-04-30
Active, closed
Eli Lilly and Company
Phase 3
974
Chūōku, Kamakura-shi, Matsuyama, Yamato-shi
2025-04-30
Recruiting
Effect of Dotinurad in Hyperuricemia With Hypertension
NCT06834230Hyperuricemia or Gout, Hypertension
Saga University
Phase 4
360
Saga
2025-03-28
Active, closed
Novartis Pharmaceuticals
Phase 2
396
Suita, Chuo Ku, Chuo-ku, Shinjuku Ku
2025-03-26
Recruiting
Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2
NCT06694012Type 2 Diabetes Mellitus (T2DM), Type 2 Diabetes, Diabetes Mellitus, Hypertension
Osaka Metropolitan University
Observational
2,000
Sakai
2024-11-01
Active, closed
Otsuka Medical Devices Co., Ltd. Japan
Not applicable
154
Hirosaki-shi, Urayasu-shi, Toon-shi, Chikushino-shi, Fukuoka, Kurume-shi, Iwaki, Seki-shi
2022-07-01
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-japan/condition/hypertension

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,516 studies in total at the last sync on 12 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies listing the condition Hypertension.

How many Hypertension trials are recruiting in Japan?

7 of the 15 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:19 UTC sync. A further 3 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hypertension), 15 studies
PhaseStudiesRecruitingShare
Phase 36240%
Not applicable3020%
Phase 12213.3%
Phase 22113.3%
Observational116.7%
Phase 4116.7%

Most active sponsors

Lead sponsors with the most studies (Hypertension)
Lead sponsorStudiesRecruiting
Eli Lilly and Company41
Novartis Pharmaceuticals21
Alnylam Pharmaceuticals11
Boehringer Ingelheim11
Chinese Academy of Medical Sciences, Fuwai Hospital10
Hiroshima University10
Innovent Biologics (Suzhou) Co. Ltd.11
Novo Nordisk A/S10
Osaka Metropolitan University11
Otsuka Medical Devices Co., Ltd. Japan10
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.